Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo  >  Biofermin Pharmaceutical Co., Ltd.    4517   JP3799800002

BIOFERMIN PHARMACEUTICAL CO., LTD.

(4517)
  Report  
No quotes available
-- JPY   --.--%
 SummaryChartsCalendarCompanyFinancialsConsensusRevisions 
Financials (JPY)
Sales 2020 -
EBIT 2020 -
Net income 2020 -
Debt 2020 -
Yield 2020 -
Sales 2021 -
EBIT 2021 -
Net income 2021 -
Debt 2021 -
Yield 2021 -
P/E ratio 2020 -
P/E ratio 2021 -
Capi. / Sales2020 -
Capi. / Sales2021 -
Capitalization 28 668 M
More Financials
Company
BIOFERMIN PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals, quasi-drugs and food products. Its products include constipating agent, anti-diarrheal agent, stomachic and digestion tablets, vitamin C (VC), laxative, food raw materials and... 
Sector
Pharmaceuticals
Calendar
01/29Earnings Release
More about the company
Latest news on BIOFERMIN PHARMACEUTICAL C

- No features available -

More news
News in other languages on BIOFERMIN PHARMACEUTICAL C

- No features available -

More news
Sector news : Pharmaceuticals - NEC
05:16pBRISTOL MYERS SQUIBB : Bluebird Bio Release Results of KarMMa Phase 2 Study
DJ
04:49pJOHNSON & JOHNSON : Janssen Says Investigational Treatment for Myeloma Gets FDA ..
DJ
03:09pAMGEN : Says FDA Approves Avsola for Same Indications as Remicade
DJ
12:31pBRISTOL-MYERS, ACCELERON : FDA Drops Planned Panel Review of Reblozyl
DJ
11:59aBAYER : to Hold Settlement Talks for Some Glyphosate Suits --Reuters
DJ
More sector news : Pharmaceuticals - NEC
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Average target price
Last Close Price 2 400,00  
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Osamu Kitatani President & Representative Director
Ken Uehara Chairman
Toshimichi Kunori Director & Managing Executive Officer
Nobuyuki Otsuki Independent Outside Director
Hitoshi Inuga Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BIOFERMIN PHARMACEUTICAL CO., LTD.-3.34%264
JOHNSON & JOHNSON8.14%367 304
ROCHE HOLDING AG25.10%263 429
MERCK AND COMPANY16.15%225 956
PFIZER-12.88%210 463
NOVARTIS21.74%207 450